FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2183657622> ?p ?o ?g. }

• W2183657622 endingPage "8" @default.
• W2183657622 startingPage "182" @default.
• W2183657622 abstract "Fibromyalgia (FMS) is a chronic syndrome characterized by widespread pain, troubled sleep, disturbed mood, and fatigue. Several analgesic strategies have been evaluated but the results are moderate and inconsistent. Antidepressant agents are now considered the treatment of choice in most patients. It has been recently suggested that FMS may be associated with metabolic alterations including a deficit of carnitine. In this multicenter randomized clinical trial we evaluated the efficacy of acetyl L-carnitine (LAC) in patients with overt FMS.One hundred and two patients meeting the American College of Rheumatology criteria for FMS were randomized into the study. The treatment consisted of 2 capsules/day of 500 mg LAC or placebo plus one intramuscular (i.m.) injection of either 500 mg LAC or placebo for 2 weeks. During the following 8 weeks the patients took 3 capsules daily containing either 500 mg LAC or placebo. The patients were seen during treatment after 2 (visit 3), 6 (visit 4) and 10 weeks (visit 5). The patients were also visited 4 weeks after treatment discontinuation (follow-up visit). Outcome measures included the number of positive tender points, the sum of pain threshold (kg/cm2 or total myalgic score), the Short Form 36 (SF36), a 100 mm visual analog scale (VAS) for self-perceived stiffness, fatigue, tiredness on awakening, sleep, work status, depression, and muscular-skeletal pain, and the Hamilton depression scale.The total myalgic score and the number of positive tender points declined significantly and equally in both groups until the 6th week of treatment. At the 10th week both parameters remained unchanged in the placebo group but they continued to improve in the LAC group with a statistically significant between-group difference. Most VAS scores significantly improved in both groups. A statistically significant between-group difference was observed for depression and musculo-skeletal pain. Significantly larger improvements in SF36 questionnaire were observed in LAC than in placebo group for most parameters. Treatment was well-tolerated.Although this experience deserves further studies, these results indicate that LAC may be of benefit in patients with FMS, providing improvement in pain as well as the general and mental health of these patients." @default.
• W2183657622 created "2016-06-24" @default.
• W2183657622 creator A5010236510 @default.
• W2183657622 creator A5013752581 @default.
• W2183657622 creator A5014482226 @default.
• W2183657622 creator A5024433998 @default.
• W2183657622 creator A5026470430 @default.
• W2183657622 creator A5038405355 @default.
• W2183657622 creator A5038627121 @default.
• W2183657622 creator A5051857373 @default.
• W2183657622 creator A5062234448 @default.
• W2183657622 creator A5074011663 @default.
• W2183657622 date "2007-06-05" @default.
• W2183657622 modified "2023-10-03" @default.
• W2183657622 title "Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patients." @default.
• W2183657622 cites W1513693607 @default.
• W2183657622 cites W1699977954 @default.
• W2183657622 cites W1725765103 @default.
• W2183657622 cites W1805213732 @default.
• W2183657622 cites W1976314545 @default.
• W2183657622 cites W1986430346 @default.
• W2183657622 cites W1988308748 @default.
• W2183657622 cites W1991777094 @default.
• W2183657622 cites W1992436256 @default.
• W2183657622 cites W2010322515 @default.
• W2183657622 cites W2018228636 @default.
• W2183657622 cites W2019119447 @default.
• W2183657622 cites W2026004981 @default.
• W2183657622 cites W2037377025 @default.
• W2183657622 cites W2039465110 @default.
• W2183657622 cites W2041481324 @default.
• W2183657622 cites W2047853158 @default.
• W2183657622 cites W2050629341 @default.
• W2183657622 cites W2076992585 @default.
• W2183657622 cites W2077318599 @default.
• W2183657622 cites W2093196756 @default.
• W2183657622 cites W2093608831 @default.
• W2183657622 cites W2097601607 @default.
• W2183657622 cites W2097648817 @default.
• W2183657622 cites W2114202011 @default.
• W2183657622 cites W2114613490 @default.
• W2183657622 cites W2147018080 @default.
• W2183657622 cites W2162376749 @default.
• W2183657622 cites W2171628509 @default.
• W2183657622 cites W2253364553 @default.
• W2183657622 cites W2341160867 @default.
• W2183657622 cites W2400333601 @default.
• W2183657622 cites W2438051866 @default.
• W2183657622 cites W45777070 @default.
• W2183657622 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17543140" @default.
• W2183657622 hasPublicationYear "2007" @default.
• W2183657622 type Work @default.
• W2183657622 sameAs 2183657622 @default.
• W2183657622 citedByCount "16" @default.
• W2183657622 countsByYear W21836576222012 @default.
• W2183657622 countsByYear W21836576222014 @default.
• W2183657622 countsByYear W21836576222015 @default.
• W2183657622 countsByYear W21836576222016 @default.
• W2183657622 countsByYear W21836576222017 @default.
• W2183657622 countsByYear W21836576222022 @default.
• W2183657622 crossrefType "journal-article" @default.
• W2183657622 hasAuthorship W2183657622A5010236510 @default.
• W2183657622 hasAuthorship W2183657622A5013752581 @default.
• W2183657622 hasAuthorship W2183657622A5014482226 @default.
• W2183657622 hasAuthorship W2183657622A5024433998 @default.
• W2183657622 hasAuthorship W2183657622A5026470430 @default.
• W2183657622 hasAuthorship W2183657622A5038405355 @default.
• W2183657622 hasAuthorship W2183657622A5038627121 @default.
• W2183657622 hasAuthorship W2183657622A5051857373 @default.
• W2183657622 hasAuthorship W2183657622A5062234448 @default.
• W2183657622 hasAuthorship W2183657622A5074011663 @default.
• W2183657622 hasConcept C118552586 @default.
• W2183657622 hasConcept C126322002 @default.
• W2183657622 hasConcept C139719470 @default.
• W2183657622 hasConcept C14184104 @default.
• W2183657622 hasConcept C142724271 @default.
• W2183657622 hasConcept C162324750 @default.
• W2183657622 hasConcept C168563851 @default.
• W2183657622 hasConcept C1862650 @default.
• W2183657622 hasConcept C198451711 @default.
• W2183657622 hasConcept C204787440 @default.
• W2183657622 hasConcept C27081682 @default.
• W2183657622 hasConcept C2776867660 @default.
• W2183657622 hasConcept C2777831278 @default.
• W2183657622 hasConcept C2778715236 @default.
• W2183657622 hasConcept C2779566273 @default.
• W2183657622 hasConcept C2780733359 @default.
• W2183657622 hasConcept C2780764818 @default.
• W2183657622 hasConcept C71924100 @default.
• W2183657622 hasConceptScore W2183657622C118552586 @default.
• W2183657622 hasConceptScore W2183657622C126322002 @default.
• W2183657622 hasConceptScore W2183657622C139719470 @default.
• W2183657622 hasConceptScore W2183657622C14184104 @default.
• W2183657622 hasConceptScore W2183657622C142724271 @default.
• W2183657622 hasConceptScore W2183657622C162324750 @default.
• W2183657622 hasConceptScore W2183657622C168563851 @default.
• W2183657622 hasConceptScore W2183657622C1862650 @default.
• W2183657622 hasConceptScore W2183657622C198451711 @default.

• next